Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution.

Marta SoteloNerea Muñoz-UncetaAntonio MatorrasPablo JaraClara CastroDiego CachoBelén CarameloAinara AzuetaIgnacio Duran

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)

In this retrospective study, atezolizumab was an effective and tolerable treatment option for patients with mUC after progression to platinum-based chemotherapy. Yet, patient selection remains critical to improve outcomes.

Keyphrases

squamous cell carcinoma
small cell lung cancer
papillary thyroid
case report
locally advanced
machine learning
radiation therapy
metabolic syndrome
combination therapy
chemotherapy induced